Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cefpodoxime poisoning |
Causative agent (attribute) |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Accidental cefpodoxime poisoning |
Causative agent (attribute) |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Intentional cefpodoxime poisoning |
Causative agent (attribute) |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Cefpodoxime poisoning of undetermined intent |
Causative agent (attribute) |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Cefpodoxime adverse reaction |
Causative agent (attribute) |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Allergy to cefpodoxime |
Causative agent (attribute) |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Cefpodoxime overdose |
Causative agent (attribute) |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Accidental cefpodoxime overdose |
Causative agent (attribute) |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Intentional cefpodoxime overdose |
Causative agent (attribute) |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Cefpodoxime overdose of undetermined intent |
Causative agent (attribute) |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Cefpodoxime 40mg/5mL pediatric suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Cefpodoxime proxetil 50mg/5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Product containing precisely cefpodoxime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Cefpodoxime proxetil 100mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Product containing cefpodoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Cefpodoxime (as cefpodoxime proxetil) 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Accidental cefpodoxime poisoning |
Causative agent (attribute) |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Intentional cefpodoxime poisoning |
Causative agent (attribute) |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Cefpodoxime proxetil |
Is a |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Allergy to cefpodoxime |
Causative agent (attribute) |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Cefpodoxime (as cefpodoxime proxetil) 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Cefpodoxime proxetil |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
|
Product containing cefpodoxime in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 8 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing only cefpodoxime (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing only cefpodoxime in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefpodoxime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefpodoxime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefpodoxime 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefpodoxime 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Cefpodoxime (as cefpodoxime proxetil) 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 100 milligram/1 each tablet for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely cefpodoxime (as cefpodoxime proxetil) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Cefpodoxime (substance) |
Inferred relationship |
Some |
1 |